• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经原性膀胱:流行病学、诊断与管理。

Neurogenic Bladder: Epidemiology, Diagnosis, and Management.

机构信息

Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery and UCL Queen Square Institute of Neurology, London, United Kingdom.

出版信息

Semin Neurol. 2020 Oct;40(5):569-579. doi: 10.1055/s-0040-1713876. Epub 2020 Oct 16.

DOI:10.1055/s-0040-1713876
PMID:33065745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9715349/
Abstract

Lower urinary tract dysfunction is a common sequel of neurological disease resulting in symptoms that significantly impacts quality of life. The site of the neurological lesion and its nature influence the pattern of dysfunction. The risk for developing upper urinary tract damage and renal failure is considerably lower in patients with slowly progressive nontraumatic neurological disorders, compared with those with spinal cord injury or spina bifida. This acknowledged difference in morbidity is considered when developing appropriate management algorithms. The preliminary evaluation consists of history taking, and a bladder diary and may be supplemented by tests such as uroflowmetry, post-void residual measurement, renal ultrasound, (video-)urodynamics, neurophysiology, and urethrocystoscopy, depending on the clinical indications. Incomplete bladder emptying is most often managed by intermittent catheterization, and storage dysfunction is managed by antimuscarinic medications. Intra-detrusor injections of onabotulinumtoxinA have revolutionized the management of neurogenic detrusor overactivity. Neuromodulation offers promise for managing both storage and voiding dysfunction. In select patients, reconstructive urological surgery may become necessary. An individualized, patient-tailored approach is required for the management of lower urinary tract dysfunction in this special population.

摘要

下尿路功能障碍是一种常见的神经病变后遗症,其症状严重影响生活质量。神经病变的部位和性质影响功能障碍的模式。与脊髓损伤或脊柱裂患者相比,患有缓慢进展性非创伤性神经疾病的患者发生上尿路损伤和肾衰竭的风险要低得多。在制定适当的管理算法时,会考虑到这种发病率的明显差异。初步评估包括病史采集、膀胱日记,根据临床指征,还可以补充尿流率、残余尿量测量、肾脏超声、(视频)尿动力学、神经生理学和尿道膀胱镜检查等检查。不完全排空膀胱通常采用间歇性导尿,储存功能障碍采用抗胆碱能药物治疗。膀胱内注射肉毒毒素 A 已彻底改变了神经源性逼尿肌过度活动症的治疗方法。神经调节为治疗储尿和排尿功能障碍提供了希望。对于某些患者,可能需要进行重建性泌尿外科手术。对于这一特殊人群的下尿路功能障碍,需要采用个体化、针对患者的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cade/9715349/09b4f9d21d68/10-1055-s-0040-1713876-i200011-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cade/9715349/4be59e2c026b/10-1055-s-0040-1713876-i200011-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cade/9715349/09b4f9d21d68/10-1055-s-0040-1713876-i200011-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cade/9715349/4be59e2c026b/10-1055-s-0040-1713876-i200011-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cade/9715349/09b4f9d21d68/10-1055-s-0040-1713876-i200011-2.jpg

相似文献

1
Neurogenic Bladder: Epidemiology, Diagnosis, and Management.神经原性膀胱:流行病学、诊断与管理。
Semin Neurol. 2020 Oct;40(5):569-579. doi: 10.1055/s-0040-1713876. Epub 2020 Oct 16.
2
Lower urinary tract dysfunction in the neurological patient: clinical assessment and management.神经系统疾病患者的下尿路功能障碍:临床评估与管理。
Lancet Neurol. 2015 Jul;14(7):720-32. doi: 10.1016/S1474-4422(15)00070-8.
3
Neurogenic lower urinary tract dysfunction.神经源性下尿路功能障碍
Handb Clin Neurol. 2013;110:209-20. doi: 10.1016/B978-0-444-52901-5.00017-4.
4
[Effectiveness and safety of sacral neuromodulation on neurogenic bladder and bowel dysfunction in patients with spina bifida].[骶神经调节对脊柱裂患者神经源性膀胱和肠道功能障碍的有效性和安全性]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2021 Nov 15;35(11):1374-1379. doi: 10.7507/1002-1892.202105112.
5
[Chronic sacral neuromodulation for pelvic floor dysfunction in children with spina bifida].[慢性骶神经调节治疗脊柱裂患儿盆底功能障碍]
Zh Vopr Neirokhir Im N N Burdenko. 2022;86(1):48-55. doi: 10.17116/neiro20228601148.
6
The management of paediatric neurogenic bladder: an approach in a resource-poor setting.小儿神经源性膀胱的管理:资源匮乏环境下的一种方法。
Paediatr Int Child Health. 2017 Nov;37(4):280-285. doi: 10.1080/20469047.2017.1351745. Epub 2017 Jul 17.
7
Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management.康复实践:神经源性下尿路功能障碍及其管理。
Clin Rehabil. 2010 Jul;24(7):579-89. doi: 10.1177/0269215509353252.
8
Neurogenic lower urinary tract dysfunction: evaluation and management.神经源性下尿路功能障碍:评估与管理
J Neurol. 2016 Dec;263(12):2555-2564. doi: 10.1007/s00415-016-8212-2. Epub 2016 Jul 11.
9
Management of neurogenic bladder in patients with multiple sclerosis.多发性硬化症患者的神经源性膀胱管理。
Nat Rev Urol. 2016 May;13(5):275-88. doi: 10.1038/nrurol.2016.53. Epub 2016 Mar 31.
10
Treatment of the neurogenic bladder in spina bifida.脊柱裂神经源性膀胱的治疗
Pediatr Nephrol. 2008 Jun;23(6):889-96. doi: 10.1007/s00467-008-0780-7.

引用本文的文献

1
Assessments of neurogenic bladder dysfunction induced by spinal cord injury, bladder outlet obstruction and diabetes: a comparative study of rat models.脊髓损伤、膀胱出口梗阻及糖尿病所致神经源性膀胱功能障碍的评估:大鼠模型的比较研究
Transl Androl Urol. 2025 Aug 30;14(8):2254-2268. doi: 10.21037/tau-2025-234. Epub 2025 Aug 26.
2
Impact of frailty and its change on urinary incontinence: A longitudinal analysis from two prospective study of ageing.衰弱及其变化对尿失禁的影响:两项前瞻性衰老研究的纵向分析
PLoS One. 2025 Aug 20;20(8):e0330062. doi: 10.1371/journal.pone.0330062. eCollection 2025.
3
[Regional variation in urinary catheter use in the Netherlands: a population-based cohort from 2012 to 2021].

本文引用的文献

1
Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder.影响经皮胫神经刺激治疗逼尿过度症维持治疗的因素。
BJU Int. 2019 May;123(5A):E20-E28. doi: 10.1111/bju.14651. Epub 2019 Feb 3.
2
Nocturia in Patients With Parkinson's Disease.帕金森病患者的夜尿症
Mov Disord Clin Pract. 2015 Dec 24;3(2):168-172. doi: 10.1002/mdc3.12279. eCollection 2016 Mar-Apr.
3
A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction.
[荷兰导尿管使用情况的地区差异:基于2012年至2021年人群的队列研究]
Tijdschr Urol. 2025;15(5):88-96. doi: 10.1007/s13629-024-00458-w. Epub 2025 Jan 21.
4
Autovaccine immunoprophylaxis in patients with neurogenic bladder experiencing recurrent urinary tract infections.神经源性膀胱伴复发性尿路感染患者的自身疫苗免疫预防
Front Immunol. 2025 Aug 1;16:1626422. doi: 10.3389/fimmu.2025.1626422. eCollection 2025.
5
Intermittent catheterization: A patient-centric approach is key to optimal management of neurogenic lower urinary tract dysfunction.间歇性导尿:以患者为中心的方法是神经源性下尿路功能障碍最佳管理的关键。
Front Urol. 2023 Mar 28;3:1158260. doi: 10.3389/fruro.2023.1158260. eCollection 2023.
6
Patient satisfaction, quality of life, and catheter-related complications in long-term urinary catheter users: a nationwide survey.长期使用导尿管患者的满意度、生活质量及导尿管相关并发症:一项全国性调查。
World J Urol. 2025 Aug 1;43(1):470. doi: 10.1007/s00345-025-05850-8.
7
Effect of a Peripheral Neuromodulation Protocol Combined with the Application of Therapeutic Exercise in Patients Diagnosed with Urinary Incontinence-A Study Protocol for a Randomized Controlled Trial.外周神经调节方案联合治疗性运动对尿失禁患者的影响——一项随机对照试验的研究方案
Healthcare (Basel). 2025 Jul 21;13(14):1759. doi: 10.3390/healthcare13141759.
8
Long-Term Effectiveness of Onabotulinum Toxin-A in a Combined Total Endoscopic Management of Pediatric Vesicoureteral Reflux in Neurogenic Bladder Dysfunction.奥曲肽毒素A在神经源性膀胱功能障碍小儿膀胱输尿管反流综合内镜治疗中的长期疗效
Toxins (Basel). 2025 Jun 29;17(7):330. doi: 10.3390/toxins17070330.
9
Urological management in people with traumatic and non-traumatic spinal cord injury in Brazil.巴西创伤性和非创伤性脊髓损伤患者的泌尿外科管理
Sci Rep. 2025 Jul 19;15(1):26215. doi: 10.1038/s41598-025-97417-1.
10
Association of urinary dysfunction after lower rectal cancer surgery with renal function: a single-center study.低位直肠癌手术后排尿功能障碍与肾功能的相关性:一项单中心研究。
Int J Colorectal Dis. 2025 Jul 14;40(1):158. doi: 10.1007/s00384-025-04955-1.
米拉贝隆治疗神经源性下尿路功能障碍患者的尿动力学疗效的一项前瞻性随机对照试验。
Neurourol Urodyn. 2018 Nov;37(8):2810-2817. doi: 10.1002/nau.23774. Epub 2018 Aug 31.
4
Bladder dysfunction as the initial presentation of multiple system atrophy: a prospective cohort study.以膀胱功能障碍为首发表现的多系统萎缩:一项前瞻性队列研究。
Clin Auton Res. 2019 Dec;29(6):627-631. doi: 10.1007/s10286-018-0550-y. Epub 2018 Jul 24.
5
Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort.米拉贝隆治疗帕金森病伴膀胱过度活动症患者的回顾性队列研究。
Parkinsonism Relat Disord. 2018 Dec;57:22-26. doi: 10.1016/j.parkreldis.2018.07.005. Epub 2018 Jul 20.
6
Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity-Prospective, randomized, double-blind, placebo-controlled study.米拉贝隆治疗神经源性逼尿肌过度活动症的疗效和安全性:前瞻性、随机、双盲、安慰剂对照研究。
Neurourol Urodyn. 2018 Sep;37(7):2226-2233. doi: 10.1002/nau.23566. Epub 2018 Mar 31.
7
Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.帕金森病和其他突触核蛋白病自主神经功能障碍的治疗。
Mov Disord. 2018 Mar;33(3):372-390. doi: 10.1002/mds.27344.
8
Open label feasibility study evaluating D-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosis.开放标签可行性研究,评估D-甘露糖联合对多发性硬化症患者疑似尿路感染进行居家监测的效果。
Neurourol Urodyn. 2017 Sep;36(7):1770-1775. doi: 10.1002/nau.23173. Epub 2016 Nov 4.
9
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.抗胆碱能药物使用与认知功能、脑代谢和认知正常老年人脑萎缩的关系。
JAMA Neurol. 2016 Jun 1;73(6):721-32. doi: 10.1001/jamaneurol.2016.0580.
10
Management of neurogenic bladder in patients with multiple sclerosis.多发性硬化症患者的神经源性膀胱管理。
Nat Rev Urol. 2016 May;13(5):275-88. doi: 10.1038/nrurol.2016.53. Epub 2016 Mar 31.